| Issue Date | Title | Author(s) |
| 2016 | Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China | Lu, Jin; Hou, Jian; Liu, Kai-Yan; Parmar, Simrit; De La Fuente, Adolfo; Andersson, Borje; Yan, ChenHua; Zhou, Daobin; Tan, Daryl; Ritchie, David; Wu, Deipei; Shpall, Elizabeth; Laport, Ginna G.; Li, JianYong; Hu, Jiong; Zhang, Lian Sheng; Wang, Michael; Malhotra, Pankaj; Jiang, Qian; Qin, Yazhen; Wong, Raymond; Champlin, Richard; Issaragrisil, Surapol; Iyer, Swaminathan; Mathews, Vikram; Wang, Yu; Hu, Yu; Xiao, Zhijian; Shao, Zonghong; Rosengarten, Rafael; Steuernagle, Jon; Xiao, Jun Huang; Orlowski, Robert; Chim, Chor Sang |
| 2016 | Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China | Liu, Junru; Huang, He; Li, Yan; Liu, Lin; Li, Jianyong; Liu, Zhuogang; Lu, Jin; Ouyang, Jian; Song, Yongping; Zhou, Daobin; Ren, Hanyun; Ma, Jun; Wang, Chun; Yu, Li; Zhou, Jin; Wang, Jianmin; Xiao, Yang; Huang, Xiaojun; Li, Juan |
| 2017 | Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China | Huang, Xiao Jun; Liu, Kaiyan; Ritchie, David; Andersson, Borje; Lu, Jin; Hou, Jian; Burguera, Adolfo de la Fuente; Wang, JianXiang; Yeoh, Allen; Yan, Chenhua; Zhou, Daobin; Tan, Daryl; Kim, Dong Wook; Wu, Depei; Shpall, Elizabeth; Kornblau, Stephen; Neelapu, Sattava; Hongeng, Suradej; Li, Jianyong; Hu, Jiong; Zhang, Lian Sheng; Wang, Michael; Malhotra, Pankaj; Jiang, Qian; Qin, Yazhen; Wong, Raymond; Champlin, Richard; Hagemeister, Frederick; Westin, Jason; Iyer, Swaminathan; Mathews, Vikram; Wang, Yu; Hu, Yu; Xiao, Zhijian; Shao, Zonghong |
| 2023 | Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma | Song, Yuqin; Zhou, Keshu; Yang, Shenmiao; Hu, Jianda; Zou, Dehui; Gao, Sujun; Pan, Ling; Wang, Tingyu; Yang, Haiyan; Zhang, Huilai; Zhou, Daobin; Ji, Jie; Xu, Wei; Feng, Ru; Jin, Jie; Lv, Fangfang; Huang, Haiwen; Fan, Xiaosi; Xu, Sheng; Zhu, Jun |
| 2023 | Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis | Song, Yuqin; Zhou, Keshu; Zou, Dehui; Li, Dengju; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Tam, Constantine S.; Simpson, David; Wang, Michael; Phillips, Tycel J.; Opat, Stephen; Fang, Cheng; Sun, Shaohui; Zhu, Jun |
| 15-Nov-2022 | Long-Term Outcomes of Second-Line Vs Later-Line Zanubrutinib Treatment in Patients with Relapsed/Refractory MCL: An Updated Pooled Analysis | Song, Yuqin; Zhou, Keshu; Zou, Dehui; Li, Dengju; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Tam, Constantine S.; Simpson, David; Wang, Michael L.; Phillips, Tycel J.; Opat, Stephen; Fang, Cheng; Sun, Shaohui; Zhu, Jun |
| 4-Nov-2021 | A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China | Liu, Weiping; Zhao, Donglu; Liu, Ting; Niu, Ting; Song, Yongping; Xu, Wei; Jin, Jie; Cai, Qingqing; Huang, Huiqiang; Li, Zhiming; Hou, Ming; Zhang, Huilai; Zhou, Jianfeng; Hu, Jianda; Shen, Jianzhen; Shi, Yuankai; Yang, Yu; Zhang, Liling; Zhao, Weili; Ding, Kaiyang; Qiu, Lugui; Tan, Huo; Zhang, Zhihui; Liu, Lihong; Wang, Jinghua; Xu, Bing; Zhou, Hui; Gao, Guangxun; Xue, Hongwei; Bai, Ou; Feng, Ru; Huang, Xiaobing; Yang, Haiyan; Yan, Xiaojing; Zeng, Qingshu; Liu, Peng; Li, Wenyu; Mao, Min; Su, Hang; Wang, Xin; Xu, Jingyan; Zhou, Daobin; Zhang, Hongyu; Ma, Jun; Shen, Zhixiang; Zhu, Jun |
| 1-Jun-2021 | A Novel Mechanism of Action of Histone Deacetylase Inhibitor Chidamide: Enhancing the Chemotaxis Function of Circulating PD-1(+) Cells From Patients With PTCL | Wei, Chong; Hu, Shaoxuan; Luo, Mingjie; Chen, Chong; Wang, Wei; Zhang, Wei; Zhou, Daobin |
| 2015 | Phase II Study of Chidamide, a New Subtype-Selective Oral Histone Deacetylase Inhibitor, in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma | Shi, Yuankai; Dong, Mei; Zhu, Jun; Zhou, Daobin; Huang, Huiqiang; Tu, Ping; Zhang, Weijing; Hong, Xiaonan; Zhao, Xielan; Sun, Jianfang; Liu, Yuehua; Qiu, Lugui; Shen, ZhiXiang; Feng, Jifeng; Ke, Xiaoyan |
| 2015 | Phase II Study of Chidamide, a New Subtype-Selective Oral Histone Deacetylase Inhibitor, in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma | Shi, Yuankai; Dong, Mei; Zhu, Jun; Zhou, Daobin; Huang, Huiqiang; Tu, Ping; Zhang, Weijing; Hong, Xiaonan; Zhao, Xielan; Sun, Jianfang; Liu, Yuehua; Qiu, Lugui; Shen, ZhiXiang; Feng, Jifeng; Ke, Xiaoyan |
| 2018 | Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin's lymphoma: a randomized Phase 3 study | Zhu, Jun; Huang, Huiqiang; Chen, Huan; Zhang, Xi; Li, Zengjun; Wu, Depei; Zhou, Daobin; Song, Yongping; Hu, Yu; Liang, Yingmin; Ren, Hanyun; Huang, He; Li, Nainong; Chen, Hu; Hu, Jiong; Li, Jianyong; Meng, Robin; Wu, Junlong; Yu, Dong; Huang, Xiaojun |
| Jul-2022 | Prognostic implications of the detection of measurable residual disease and mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA | Wang, Jing; Jiang, Hao; Jing, Yu; Su, Long; Liu, Daihong; Zhou, Daobin; Wang, Jingbo; Liu, Hui; Ruan, Guo Rui; Gao, Sujun; Huang, Xiao Jun |
| 2017 | Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study | Hou, Jian; Jin, Jie; Xu, Yan; Wu, Depei; Ke, Xiaoyan; Zhou, Daobin; Lu, Jin; Du, Xin; Chen, Xiequn; Li, Junmin; Liu, Jing; Gupta, Neeraj; Hanley, Michael J.; Li, Hongmei; Hua, Zhaowei; Wang, Bingxia; Zhang, Xiaoquan; Wang, Hui; van de Velde, Helgi; Richardson, Paul G.; Moreau, Philippe |
| May-2020 | Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia | Chen, Miao; Zhuang, Junling; Yang, Chen; Zhang, Lu; Wang, Wei; Cai, Huacong; Yu, Yanfang; Li, Jian; Zhou, Daobin; Han, Bing |
| 2018 | Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial | Song, Yuqin; Zhou, Keshu; Zou, Dehui; Zhou, Jianfeng; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Guo, Haiyi; Wang, Aihua; Hilger, James; Huang, Jane; Novotny, William; Osman, Muhtar; Zhu, Jun |
| 2018 | Spliceosome Mutations Are Common in MPN-Associated Myelofibrosis with RBC-Transfusion-Dependence and Correlate with Response to Pomalidomide | Chowdhury, Onima; O'Sullivan, Jennifer; Barkas, Nikolas; Buck, Gemma; Hamblin, Angela; Tefferi, Ayalew; Al-Ali, Haifa; Barosi, Giovanni; Devos, Timothy; Gisslinger, Heinz; Jiang, Qian; Kiladjian, Jean-Jacques; Mesa, Ruben A.; Passamonti, Francesco; Ribrag, Vincent; Schiller, Gary J.; Vannucchi, Alessandro M.; Zhou, Daobin; McMullin, Mary Frances; Reiser, David; Zhong, Jim; Gale, Robert Peter; Mead, Adam J. |
| Aug-2020 | Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide | Chowdhury, Onima; O'Sullivan, Jennifer; Barkas, Nikolaos; Wang, Guanlin; Buck, Gemma; Hamblin, Angela; Tefferi, Ayalew; Al-Ali, Haifa K.; Barosi, Giovanni; Devos, Timothy; Gisslinger, Heinz; Jiang, Qian; Kiladjian, Jean-Jacques; Mesa, Ruben; Passamonti, Francesco; Ribrag, Vincent; Schiller, Gary; Vannucchi, Alessandro M.; Zhou, Daobin; McMullin, Mary Frances; Zhong, Jianhua; Gale, Robert Peter; Mead, Adam J. |
| 11-May-2020 | Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study | Xu, Wei; Yang, Shenmiao; Zhou, Keshu; Pan, Ling; Li, Zengjun; Zhou, Jianfeng; Gao, Sujun; Zhou, Daobin; Hu, Jianda; Feng, Ru; Huang, Haiwen; Ji, Meng; Guo, Haiyi; Huang, Jane; Novotny, William; Feng, Shibao; Li, Jianyong |
| Feb-2023 | Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis | Xu, Wei; Yang, Shenmiao; Zhou, Keshu; Pan, Ling; Li, Zengjun; Gao, Sujun; Zhou, Daobin; Hu, Jianda; Feng, Ru; Huang, Haiwen; Wang, Tingyu; Li, Dengju; Ji, Meng; Guo, Haiyi; Zhao, Xia; Wu, Binghao; Yu, Yiling; Wang, Yu; Huang, Jane; Novotny, William; Li, Jianyong |
| Jul-2022 | Zanubrutinib Monotherapy for Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies | Xu, Wei; Yang, Shenmiao; Tam, Constantine S.; Seymour, John F.; Zhou, Keshu; Opat, Stephen; Qiu, Lugui; Sun, Mingyuan; Wang, Tingyu; Trotman, Judith; Pan, Ling; Gao, Sujun; Zhou, Jianfeng; Zhou, Daobin; Zhu, Jun; Song, Yuqin; Hu, Jianda; Feng, Ru; Huang, Haiwen; Su, Dan; Shi, Miao; Li, Jianyong |
